• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝血管瘤中 1 型碘甲状腺原氨酸脱碘酶(D1)的酶活性较低:一项初步研究。

The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in liver hemangioma: a preliminary study.

机构信息

Department of General, Transplant, and Liver Surgery, Warsaw Medical University, Banacha 1A, Warsaw, Poland.

出版信息

Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):77-80. doi: 10.1007/s00005-009-0056-3. Epub 2010 Jan 5.

DOI:10.1007/s00005-009-0056-3
PMID:20049650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2816262/
Abstract

Type 1 iodothyronine deiodinase (D1) is a crucial enzyme which converts the prohormone thyroxine (T4) into active tri-iodothyronine (T3). There has been strong evidence that the metabolism of thyroid hormones is disturbed in some neoplastic tissues such as thyroid, renal, and breast cancer. However, there are few available data about D1 enzyme activity in benign tumors such as hemangioma, which is the most common primary liver tumor. Hence this study aimed to determine the enzymatic activity of D1 in hemangiomas in relation to healthy liver tissue. Seven tumors and healthy control tissues were obtained from patients who had liver resection due to hemangioma. The activity was assessed by measurement of radioactive iodine released by deiodination catalyzed by D1. It was found that D1 activity was significantly lower in the hemangiomas than in the healthy surrounding tissue (p = 0.0017). The results indicated that thyroid hormones play important roles not only in the regulation of cell metabolism, but also in cell growth, division, and apoptosis. The active form T3 acts through its nuclear receptors and influences the up- and down-regulation of target genes. Healthy liver tissue expresses a high level of D1, but disturbed D1 activity may result in changes in the local concentration of T3 which may impair gene transcription. These finding demonstrate a low enzymatic activity of D1 in liver hemangioma and suggest an as yet unknown role of thyroid hormones in this type of benign liver tumor.

摘要

类型 1 碘甲状腺原氨酸脱碘酶 (D1) 是一种关键的酶,可将前激素甲状腺素 (T4) 转化为活性三碘甲状腺原氨酸 (T3)。有强有力的证据表明,甲状腺激素的代谢在某些肿瘤组织中受到干扰,如甲状腺、肾和乳腺癌。然而,关于良性肿瘤(如血管瘤)中 D1 酶活性的可用数据很少,血管瘤是最常见的原发性肝肿瘤。因此,本研究旨在确定 D1 在血管瘤中的酶活性与健康肝组织的关系。从因血管瘤而行肝切除术的患者中获得了 7 个肿瘤和健康对照组织。通过测量 D1 催化的脱碘作用释放的放射性碘来评估活性。结果发现,D1 活性在血管瘤中明显低于周围健康组织(p = 0.0017)。结果表明,甲状腺激素不仅在细胞代谢调节中起着重要作用,而且在细胞生长、分裂和凋亡中也起着重要作用。活性形式 T3 通过其核受体发挥作用,并影响靶基因的上调和下调。健康肝组织表达高水平的 D1,但 D1 活性的紊乱可能导致 T3 的局部浓度发生变化,从而损害基因转录。这些发现表明肝血管瘤中 D1 的酶活性较低,并提示甲状腺激素在这种良性肝肿瘤中具有未知的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7d/2816262/2a0c534ab97e/5_2009_56_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7d/2816262/07381ec1c365/5_2009_56_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7d/2816262/2a0c534ab97e/5_2009_56_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7d/2816262/07381ec1c365/5_2009_56_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb7d/2816262/2a0c534ab97e/5_2009_56_Fig2_HTML.jpg

相似文献

1
The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in liver hemangioma: a preliminary study.肝血管瘤中 1 型碘甲状腺原氨酸脱碘酶(D1)的酶活性较低:一项初步研究。
Arch Immunol Ther Exp (Warsz). 2010 Feb;58(1):77-80. doi: 10.1007/s00005-009-0056-3. Epub 2010 Jan 5.
2
Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors.1 型碘甲状腺原氨酸脱碘酶在选定肝肿瘤中的酶活性。
Arch Med Sci. 2014 Aug 29;10(4):801-5. doi: 10.5114/aoms.2013.34323. Epub 2013 Aug 20.
3
Iodothyronine deiodinases and the control of plasma and tissue thyroid hormone levels in hyperthyroid tilapia (Oreochromis niloticus).甲状腺原氨酸脱碘酶与甲状腺功能亢进罗非鱼(尼罗罗非鱼)血浆和组织甲状腺激素水平的调控
J Endocrinol. 2005 Mar;184(3):467-79. doi: 10.1677/joe.1.05986.
4
[Iodothyronine deiodinases expression in thyroid neoplasias].[甲状腺肿瘤中碘甲状腺原氨酸脱碘酶的表达]
Arq Bras Endocrinol Metabol. 2007 Jul;51(5):690-700. doi: 10.1590/s0004-27302007000500006.
5
Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism.增生性肝血管瘤伴消耗性甲状腺功能减退时 3 型碘甲状腺原氨酸脱碘酶活性增加。
Eur J Pediatr. 2010 Feb;169(2):215-21. doi: 10.1007/s00431-009-1009-x. Epub 2009 Jun 23.
6
Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-pubertal and adult rats.青春期前和成年大鼠甲状腺功能及1型碘甲状腺原氨酸脱碘酶活性的性别差异。
J Endocrinol. 2007 Jan;192(1):121-30. doi: 10.1677/joe.1.06901.
7
Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.FRTL5细胞中的碘甲状腺原氨酸脱碘酶活性:I型5'-脱碘酶占主导。
Endocrinology. 1990 Jun;126(6):3059-68. doi: 10.1210/endo-126-6-3059.
8
Acute pretranslational regulation of type III iodothyronine deiodinase by growth hormone and dexamethasone in chicken embryos.生长激素和地塞米松对鸡胚III型碘甲状腺原氨酸脱碘酶的急性翻译前调节
Mol Cell Endocrinol. 1999 Jan 25;147(1-2):49-56. doi: 10.1016/s0303-7207(98)00218-4.
9
Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness.长期危重病模型中组织碘甲状腺原氨酸脱碘酶活性的调节
Thyroid. 2008 May;18(5):551-60. doi: 10.1089/thy.2007.0287.
10
Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.婴儿血管瘤中3型碘甲状腺原氨酸脱碘酶引起的严重甲状腺功能减退症。
N Engl J Med. 2000 Jul 20;343(3):185-9. doi: 10.1056/NEJM200007203430305.

引用本文的文献

1
Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors.1 型碘甲状腺原氨酸脱碘酶在选定肝肿瘤中的酶活性。
Arch Med Sci. 2014 Aug 29;10(4):801-5. doi: 10.5114/aoms.2013.34323. Epub 2013 Aug 20.
2
Iodothyronine deiodinases and cancer.碘甲状腺原氨酸脱碘酶与癌症。
J Endocrinol Invest. 2011 Oct;34(9):716-28. doi: 10.3275/7754. Epub 2011 May 27.

本文引用的文献

1
Human breast cancer tissue expresses high level of type 1 5'-deiodinase.人类乳腺癌组织表达高水平的1型5'-脱碘酶。
Thyroid. 2007 Jan;17(1):3-10. doi: 10.1089/thy.2006.0012.
2
Morphologic, phenotypic and functional characteristics of endothelial cells derived from human hepatic cavernous hemangioma.源自人肝脏海绵状血管瘤的内皮细胞的形态学、表型和功能特征
J Vasc Res. 2006;43(6):522-32. doi: 10.1159/000095965. Epub 2006 Sep 28.
3
Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in papillary thyroid cancer.
甲状腺乳头状癌中1型和2型碘甲状腺原氨酸脱碘酶以及TITF1/NKX2-1和PAX-8转录因子基因的表达紊乱。
Thyroid. 2005 Oct;15(10):1137-46. doi: 10.1089/thy.2005.15.1137.
4
Physiology and pathophysiology of type 3 deiodinase in humans.人类3型脱碘酶的生理学与病理生理学
Thyroid. 2005 Aug;15(8):875-81. doi: 10.1089/thy.2005.15.875.
5
Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans.2型碘甲状腺原氨酸脱碘酶是甲状腺功能正常的人体内血浆T3的主要来源。
J Clin Invest. 2005 Sep;115(9):2524-33. doi: 10.1172/JCI25083. Epub 2005 Aug 25.
6
Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase.转化生长因子-β通过转录刺激3型碘甲状腺原氨酸脱碘酶促进细胞外甲状腺激素失活。
Mol Endocrinol. 2005 Dec;19(12):3126-36. doi: 10.1210/me.2005-0173. Epub 2005 Jul 21.
7
Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.1型碘甲状腺原氨酸脱碘酶表达降低可能是甲状腺细胞向乳头状癌去分化过程中的一个早期且独特的事件。
Clin Endocrinol (Oxf). 2005 Jun;62(6):672-8. doi: 10.1111/j.1365-2265.2005.02277.x.
8
New insight into the pathophysiology of severe hypothyroidism in an infant with multiple hepatic hemangiomas.一名患有多发性肝血管瘤婴儿的严重甲状腺功能减退症病理生理学新见解。
J Pediatr Endocrinol Metab. 2005 May;18(5):511-4. doi: 10.1515/jpem.2005.18.5.511.
9
Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors.基因表达谱显示,双调蛋白聚糖、脱碘酶1和脱碘酶2在甲状腺良恶性肿瘤中表达不足。
Thyroid. 2005 Mar;15(3):210-21. doi: 10.1089/thy.2005.15.210.
10
Spontaneous regression of severe acquired infantile hypothyroidism associated with multiple liver hemangiomas.与多发性肝脏血管瘤相关的严重获得性婴儿甲状腺功能减退症的自发消退。
Pediatrics. 2003 Dec;112(6 Pt 1):1424-6. doi: 10.1542/peds.112.6.1424.